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ABSTRACT 
Objective: A simple, precise, and accurate spectrophotometric method has been developed to determine Ampicillin in pharmaceutical formulations. 
Methods: The proposed method, based on the carboxylic acid group reaction, present in Ampicillin with a mixture of KIO3
Results: The yellow-colored product was measured at 352 nm against the reagent blank using UV–Vis spectrophotometer. The linear dynamic 
range of concentration was 0.25–2.5 µg/ml with a correlation coefficient of 0.9999. The LOD, LOQ values to be 0.086 and 0.261 µg/ml, respectively, 
for the proposed method. The percentage of recoveries was 98.27–100.89% with an acceptable relative standard deviation (±2%). The robustness 
and ruggedness values were excellent.  
 and KI, form a yellow-
colored product in an aqueous medium. The response was allowed to proceed at 25±1 °C, and absorbance measured after 5 min against a reagent 
blank prepared simultaneously using a UV-Vis spectrophotometer. The parameters verified were specificity, linearity, linearity range, accuracy, 
precision, detection limit, quantitation limit, robustness, and ruggedness.  
Conclusion: The ICH guidelines for pharmaceuticals and human use were followed and applied to validate the proposed method. The method was 
compared with available literature and found similar results that confirmed the reliability and effective way for Ampicillin's determination.  
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INTRODUCTION 
Ampicillin is semi-synthetic antibiotics with broad antimicrobial 
properties., chemically known as (2S,5R,6R)-6-([(2R)-2-amino-2-
phenylacetyl]amino)3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0] 
heptane-2-carboxylic acid (fig. 1). It is an amphoteric compound and 
acts as an aliphatic amino acid. It has been a therapeutic drug 
against many gram-positive microorganisms. It is still more active 
with gram-negative microorganisms due to its enhanced ability to 














Fig. 1: Structure of penicillin-type antibiotic drug, Ampicillin 
 
Ampicillin is available in tablets, capsules, powder for oral 
suspension and injection as commercial usage since 1961 [1]. The 
extensive literature survey revealed that several analytical 
techniques, likely as high–performance liquid chromatography 
(HPLC) [2, 3], capillary electrophoresis (CE) [4, 5], Fourier–
transform infrared spectroscopy (FTIR) [6] were available for the 
determination in bulk and pharmaceutical formulations. It can be 
quantified with liquid chromatography-mass spectrophotometry 
(LCMS) [7] and ultra-performance liquid chromatography-mass 
spectrophotometry (UPLC–MS) [8] in biological fluids. Most of the 
techniques are involved with the complicated procedure, extraction 
with toxic solvents, and expensive instrumentation and 
pretreatment of the sample before analysis. However, Ultraviolet-
Visible (UV-Vis) spectrophotometer is a convenient technique for 
the study of pharmaceuticals. Generally, the quantification without 
any pretreatment procedure before analysis [9–13]. Ampicillin as 
well can be quantified in bulk and drugs [14, 15]. The presented 
paper describes a fast, sensitive, and economical method for 
determining Ampicillin in pharmaceutical formulations. The 
procedure was based on the reaction of a carboxylic acid group of 
Ampicillin with a mixture of potassium iodate (KIO3
MATERIALS AND METHODS 
) and potassium 
iodide (KI) to form a yellow-colored product in an aqueous medium 
at room temperature (25 °C), followed spectrophotometrically by 
measuring the absorbance at 352 nm.  
Apparatus 
The spectrophotometer, Cecil (CE 7400, UK), with a 1 cm glass cell 
was applied to carry out all the spectral runs.  
Materials and reagents 
The pharmaceutical formulation products of Ampicillin such as 
Ampicyn 500 (Cipla Limited, India), Campicillin 250 (Cadila 
Pharmaceuticals, India), and Ampiclox 500 (GlaxoSmithKline, UK) 
were brought from the local pharmacy. Potassium iodate and 
potassium iodide purchased from Sigma Aldrich, USA, and prepared 
solutions in distilled water with 2.5×10-3 and 2.5×10-2
Extraction of ampicillin from the dosage form 
 M, 
respectively. 
Ampicillin (500 mg/capsule) powder materials were transferred 
into a 250 ml volumetric flask and dissolved with distilled water. 
The separation was continued with column chromatography using 
silica gel as a stationary phase and water: methanol: glacial acetic 
acid (1.2: 8.5: 0.3 v/v/v) as mobile phase. The target compound was 
separated and dried as solid Ampicillin. 
Standard Ampicillin solutions 
The standard Ampicillin solution (50 µg/ml) was prepared in 
distilled water and diluted as per the requirement.  
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Optimization of variables 
The parameters were thoroughly studied related to the color 
development of the product. Therefore, several conditions were 
optimized during quantification and maintained their optimum 
value throughout the determination process. 
Potassium iodate (KIO3
The effect of volume of potassium iodate (2.5×10
) concentration 
−3 M) was 
investigated in the range of 0.1–1.5 ml, keeping ampicillin (2.5 
µg/ml) and KI (1.25×10−3 M) as constant. The absorbance was 
increased with the increasing volume of KIO3 and became steady at 
1.1 ml. Further addition of work does not have any impact on the 
color development of the product. Therefore, 1.3 ml used as an 
optimum volume throughout the experiment for KIO3
Potassium iodide (KI) concentration 
. 
The effect of volume of potassium iodide (2.5×10−2 M) was 
investigated for product's color development in the range of 0.2–2.2 
ml, keeping ampicillin (2.5 µg/ml) and KIO3 (7.5×10−5
The proposed procedure for the determination of Ampicillin 
 M) as 
constant. The maximum intensity of the colored product gave rise to 
1.8 ml of KI, and a further increase in the volume did not affect the 
absorbance. Thus, the proposed procedure used 2 ml as constant 
throughout the experiment for KI. 
Into a series of 50 ml volumetric flasks, different volumes of 
Ampicillin (50 µg/ml) corresponds to 0.25–2.50 µg/ml added with 2 
ml of KI (2.5×10-2 M) and 1.3 ml of KIO3 (2.5×10-3
Analysis of pharmaceutical formulations 
 M). The final 
volume was made up of distilled water and shook the mixture well 
enough to mix them properly. The reaction's equilibrium achieves 
after 5 min; therefore, 5 min is used as the equilibrium time for its 
determination. Absorbance was recorded for all standard samples at 
352 nm and applied to construct a regression equation against 
Ampicillin's initial concentrations [16]. The intraday and interday 
precision of the proposed methods were established by measuring 
Ampicillin's content at three different concentration levels (low, 
medium, and high) at 0.5. 1.25 and 2 µg/ml within one day and five 
consecutive days, respectively. Ampicillin, with a known amount 
(0.5 µg/ml) in dosage form, was spiked with 100%, 200%, and 
300% of additional Ampicillin pure drug, respectively, and 
determine the accuracy, precision of the proposed method following 
the recommended procedure as ICH guidelines [17–19]. 
Two ampicillin (label claim: 250 mg) capsules were mixed with 250 
ml distilled water and kept for 30 min after stirred. After filtration to 
recover the drugs completely, repeated the washing steps several 
times. This solution was used for further process and applied the 
above procedure to determine the Ampicillin in pharmaceutical 
formulations.  
RESULTS AND DISCUSSION 
Reaction with a mixture of iodide and iodate 
The literature reported [20] iodine formed by the interaction 
between potassium iodate and potassium iodide due to organic and 
inorganic acid reaction by the below equation.  
5 I-+IO3-+6 H+→ 3 H2O+3 I
The liberated iodine reacted with excess iodide ions to yield a 
triiodide ion (I
2 
2+I-→I3 -), which absorbs maximally at 352 nm. It was 
the fundamental mechanism to develop a spectrophotometric 
method for Ampicillin as it contains–COOH group in its moiety. The 
reaction mechanism suggested in Scheme 1 as per the above 
reaction. The communicated process corresponds to Ampicillin 
(0.25–2.50 µg/ml) was reacted with 1.3 ml KIO3 (fig.2) and 2 ml 
KIO3
 































Scheme 1: Formation of triiodide ion that measures spectrophotometrically at 352 nm 
 
 
Fig. 2: Effect of the volume of potassium iodate (2.5×10−3 M) on the absorbance of the product, Ampicillin (2.5 µg/ ml), and KI (1.25×10−3 M) 
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Fig. 3: Effect of the volume of potassium iodide (2.5×10−2 M) on the absorbance of the product, Ampicillin (2.5 µg/ ml), and KIO3  (7.5×10−5
 
 M) 
Validation of proposed methods  
Specificity 
The proposed method's specificity was evaluated by preparing a 
synthetic mixture of bulk drugs with common excipients used in the 
tablet formulations. It observed that no interference of excipients 
during the quantification drug.  
Linearity and linear range 
Under the optimized experimental conditions, the absorbance and 
concentration were linear within the range of 0.25–2.5 µg/ml (fig. 
4). The statistical treatment of the data yielded the linear regression 
equation A = 0.0035+0.4227 C. The statistical regression data 
provided the slope, intercept, detection limits, quantitation, and 
results summarized in table 1. All the parameters were important as 
per the guidelines and considered during the validation of the 
developed method. 
Accuracy and precision  
The intraday and interday precision have resulted in an Ampicillin 
concentration of 0.5, 1.25, and 2 µg/ml (table 2). The % RSD was 
in the range of 0.24–1.81 % within±2%. The recovery studies of 
each concentration level established the accuracy of the method. 
The procedure's % recovery was in the range of 99.32–100.65 % 




Fig. 4: Linearity of the proposed method 
 
Table 1: Optical and regression characteristics of the proposed method 
Parameters Values 
λ 352 nm max 
Calibration equation A = 0.0035+0.4227 C 
Linear dynamic range (µg/ml) 0.25–2.5 






2 0.9999 ) 
Detection limit (µg/ml) 0.086 
Quantitation limit (µg/ml) 0.261 
 
Table 2: Summary of accuracy and precision results of the proposed method 
Proposed method Amount (µg/ml) % Recovery % RSD 
Taken Found±SDa 
Intraday  0.75 0.756±0.014 100.89 1.81 
 1.50 1.497±0.004 99.81 0.24 
 2.25 2.234±0.006 99.27 0.27 
Interday  0.75 0.741±0.014 98.78 1.84 
 1.50 1.502±0.005 100.12 0.328 
 2.25 2.231±0.01 99.17 0.441 
aMean for five independent analyses, SD, standard deviation, RSD, relative standard deviation 
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Table 3: Summary of accuracy and precision results of the proposed method for ampicillin pharmaceutical formulations 
Proposed method Amount (µg/ml) % RSD % Recovery 
Taken Found±SDa 
Ampicyn-500 1.0 0.993±0.014 1.375 99.32 
Ampicyn-500 1.5 1.508±0.004 0.239 100.65 
Ampicyn-500 2.0 2.000±0.002 0.118 100.01 
Campicilin-250 1.0 0.993±0.014 1.375 99.32 
Campicilin-250 1.5 1.508±0.007 0.471 100.54 
Campicilin-250 2.0 2.001±0.001 0.068 100.05 
Ampiclox–500 1.0 0.993±0.014 1.375 99.32 
Ampiclox–500 1.5 1.508±0.004 0.239 100.65 
Ampiclox–500 2.0 2.000±0.002 0.118 100.01 
aMean for five independent analyses, SD, standard deviation, RSD, relative standard deviation, bSAE, standard analytical error, c
 
C. L., confidence limit 
at 95 % confidence level and 4 degrees of freedom (t = 2.776) 
Robustness 
The robustness study was performed at different laboratories. The 
due reason recorded the absorbance after 4.5 min and well 
continued for 5.5 min of reaction. The investigation resulted at 351 
nm and 353 nm to check the method's robustness. The procedure's 
% recovery was in the range of 98.32–99.97 % and % RSD between 
0.352–0.755 %, respectively, within the acceptable limit.  
Ruggedness  
The ruggedness test was conducted at three different concentration 
levels within the linearity range. The test was expressed in terms of 
%RSD, applied the same procedure using another UV-Vis 
spectrophotometer. The procedure's % recovery was within 98.55–
99.72 % and % RSD between 0.023–0.325 % within the acceptable 
limit of±2%. 
Application of the proposed method 
The proposed method was successfully developed and validated for 
the determination of Ampicillin in pharmaceutical formulations. The 
proposed method was compared with the reference method [3] 
using point and interval hypothesis tests. The calculated t-(paired) 
and F-values at 95% confidence level do not exceed the theoretical 
ones indicating any significant differences between the developed 
method's performances with the reference method (table 4). Table 4 
showed that all samples of the drug's actual bias were smaller than 
±2% and thus confirming that the proposed method was reliable 
with acceptable recovery. 
 
Table 4: Point and interval hypothesis tests: comparing the proposed methods with the reference method at 95% confidence level 
Formulations Proposed method Reference method 
% Recovery  % RSD  t-and F θb L and θU  % Recovery  c  % RSD  



























Theoretical t-(ν = 8) and F-values (ν = 4, 4) at 95 % confidence level are 2.306 and 6.39, respectively. θL and θU are within the acceptable limits of ±2%. 
 
CONCLUSION 
The proposed UV-Vis technique is a simple, low-cost method and can 
easily be applied to Ampicillin's routine quality control sample 
analysis in bulk and pharmaceutical formulations. It has a more 
comprehensive dynamic range for the study with excellent accuracy 
and precision value. The proposed method does not require any 
laborious cleanup procedure before analysis and simple 
methodology for its determination. Therefore, it can easily 
accommodate in the laboratories of research, hospitals, and 
pharmaceutical industries for the quantification of Ampicillin in 
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